CONMED Corporation Announces Second Quarter 2016 Financial Results

Go back to CONMED Corporation Announces Second Quarter 2016 Financial Results

Leerink Partners Downgrades CONMED (CNMD) to Market Perform

July 28, 2016 7:17 AM EDT

Leerink Partners downgraded CONMED (NASDAQ: CNMD) from Outperform to Market Perform with a price target of $47.00 (from $56.00).

Analyst Richard Newitter commented, "While we are encouraged by Airseal (Surgiquest) outperformance in the qtr, CNMD's organic revenue growth again missed expectations--on weak US ortho capital... More